← All stocks

Eikon Therapeutics, Inc.

EIKN Net buying

CIK 0001861123 #2972 in the set updated 17 Sep 2026

Bought (1 mo)

$1.03M

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$1.03M

+$1.03M against sales at will

By person

6 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Column Group IV GP, LP entity

10% owner

$1.03M (1)

—

+$1.03M

7,188,507

13.27%

$83.09M

+418.6%

Wolfe Josh

Director

—

2,294,653

4.24%

$26.52M

—

Lux Venture Partners V, LLC entity

10% owner

—

2,294,653

4.24%

$26.52M

—

Foresite Capital Management IV, LLC entity

10% owner

—

1,318,983

2.44%

$15.25M

—

PERLMUTTER ROGER M

See remarks

—

284,857

0.5259%

$3.29M

—

FRAZIER KENNETH C

Director

—

111,111

0.2051%

$1.28M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Column Group IV GP, LP

3 Sep 2026

10% owner

Buy indirect

89,200

$11.56

$1.03M

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 6 Feb 2026